| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.37 | 1e-08 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.2 | 6e-08 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.33 | 1e-07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.24 | 5e-06 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.27 | 2e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |